EQH
Equitable Holdings, Inc.
EQH's fundamentals are strong: its operating margin went from −2.8% to 16% and it returned to profit. At 11x earnings, it's trading above its usual 9.7x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
EQH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
EQH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQH.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
EQH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.3x | $22.16 | -60% |
| Forward | 6.5x | $55.63 | — |
| Fair | 9.7x | $50.28 | -9.6% |
| Current | 11x | $55.63 | — |
| Expensive | 17x | $87.41 | +57% |
Historical ranges are pointers, not guarantees.
EQH's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 6.5x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
EQH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect EQH's earnings to grow and its profitability to improve, with its revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EQH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.49 | +63% |
| Q3 2026 | $5.20 | +$8.00 |
| Q2 2026 | -$3.32 | -377% |
| Q1 2026 | -$2.85 | -178% |
| Q4 2025 | -$4.83 | -228% |
| Q3 2025 | -$2.80 | -$1.81 |
| Q2 2025 | $1.20 | -52% |
| Q1 2025 | $3.64 | +9.3% |
| Q4 2024 | $3.78 | +8.6% |
EQH has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
EQH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.9B | +168% |
| Q2 2026 | $1.7B | -30% |
| Q1 2026 | $4.2B | -7.6% |
| Q4 2025 | $3.3B | -9.5% |
| Q3 2025 | $1.5B | -53% |
| Q2 2025 | $2.4B | -33% |
| Q1 2025 | $4.6B | +105% |
| Q4 2024 | $3.6B | +67% |
EQH's revenue is recovering but still below its 2020 peak: $3.9B last quarter, up 168% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +129 points |
| Q2 2026 | -30% | -14 points |
| Q1 2026 | 21% | +17 points |
| Q4 2025 | 11% | -23 points |
| Q3 2025 | -93% | -93 points |
| Q2 2025 | -15% | -35 points |
| Q1 2025 | 3.8% | -7.3 points |
| Q4 2024 | 33% | +71 points |
EQH has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over EQH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
EQH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +342% |
| Q2 2026 | $643M | +89% |
| Q1 2026 | $499M | +216% |
| Q4 2025 | -$154M | -139% |
| Q3 2025 | $369M | -46% |
| Q2 2025 | $341M | -62% |
| Q1 2025 | $158M | +410% |
| Q4 2024 | $400M | +$792M |
EQH has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
EQH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -4.9M shares |
| 1 year | -7.7% | -22.8M shares |
| 3 years | -21% | -74.6M shares |
| 5 years | -34% | -141M shares |
| Available history | -45% | -220M shares |
EQH has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $238M |
| Q2 2026 | $366M |
| Q1 2026 | $147M |
| Q4 2025 | $277M |
| Q3 2025 | $676M |
| Q2 2025 | $235M |
| Q1 2025 | $262M |
| Q4 2024 | $260M |
EQH spent $1B buying back its own shares over the past year, down 28% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
EQH Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
EQH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 74.5 | Neutral |
EQH's weekly RSI is 66 (neutral) and its Stochastic is 75 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
EQH PE vs Financial Services Sector
| Metric | EQH | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 18% below |
| PE % | 57 | 63 | 6 pts below |
EQH is trading at 11x earnings, a 18% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
EQH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $53.4 | 4.1% above |
| 20 week MA | $51.4 | 8.1% above |
| 50 week MA | $46.4 | 20% above |
| 100 week MA | $48.8 | 14% above |
| 200 week MA | $41.4 | 34% above |
EQH has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
EQH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.6 | $25.1 | +2% |
| 2021 | $25.1 | $33.0 | +31% |
| 2022 | $33.0 | $28.6 | -13% |
| 2023 | $28.6 | $33.3 | +16% |
| 2024 | $33.3 | $47.5 | +43% |
| 2025 | $47.5 | $48.6 | +2.3% |
| 2026 YTD | $48.6 | $55.6 | +15% |
EQH has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.